رجاء توضيح معنى هذا الخبر ما المقصود منه وشكرا Med Diversified Arranges for Refinance of $40 Million Convertible Debentures Updated: Wednesday, December 19, 2001 05:07 PM ET Printer-friendly version ANDOVER, Mass.--(BUSINESS WIRE)--Dec. 19, 2001--e-MedSoft.com, dba Med Diversified (AMEX: MED, news, msgs), today announced it arranged for the sale of US $40 million of its convertible debentures ("New Debentures") to an institutional investor based in Geneva Switzerland. Med Diversified will use this new financing to retire the US $40 million convertible debentures sold to Societe Financiere du Seujet, Limited (SFSL) and its affiliate in October that are due on December 20, 2001. The New Debentures are expected to carry an interest rate of 7% per annum and will be due on June 28, 2002. The New Debentures will be convertible after January 1, 2002, at the option of the holder, into an aggregate of 13.2 million shares of Med Diversified common stock, or a resultant conversion price of approximately $3.00 per share. Med Diversified may prepay the New Debentures at any time prior to the maturity date or any conversion. The sale of the New Debentures was arranged by SFSL. Closing of the refinancing is expected to occur on or before December 31, 2001, after execution of required documentation. About Med Diversified Med Diversified operates companies in various segments within health care industry, including pharmacy, home infusion, multi-media, management, clinical respiratory services, home medical equipment, home health services and other functions. For more information, see http://www.e-medsoft.com. Statements in this news release that relate to management's expectations, intentions or beliefs concerning future plans, expectations, events and performance are "forward looking" within the meaning of the federal securities laws. These forward-looking statements include assumptions, beliefs and opinions relating to the Company's business and growth strategy based upon management's interpretation and analysis of its own contractual and legal rights, management's ability to satisfy industry and consumer needs with its technologies, health-care industry trends, and management's ability to successfully develop, implement, market and/or sell its network transaction processing services, software programs, clinical and financial transaction services, and e-commerce systems to its clientele. Management's forward-looking statements further assume that the company will be able to successfully develop and execute on its strategic relationships. Many known and unknown risks, uncertainties and other factors, including general economic conditions and risk factors detailed from time to time in news releases and the company's filings with the Securities and Exchange Commission, may cause these forward-looking statements to be incorrect in whole or in part. The investor should review such public filings to get a comprehensive picture and analysis of all conditions and circumstances. The company expressly disclaims any intent or obligation to update any forward looking statements. Actual results or events could differ materially from those anticipated in the forward-looking statements due to a variety of factors set out above, including, without limitation, integration of business and management associated with the Company's business relationships and acquisitions, acceptance by customers of the Company's products, changing technology, competition in the health-care market, government regulation of health care, the Company's limited operating history, general economic conditions, availability of capital and other factors.